Lysosomal Therapeutics, Inc. (LTI)

Lysosomal Therapeutics, Inc. (LTI) is a nonprofit-focused organization committed to researching and developing therapies for neurodegenerative diseases, leveraging lysosomal biology to address conditions affecting movement and cognition. The site presents information about the company’s mission, lead programs like LTI-291, patient resources, and updates on clinical research and leadership.
Discussion
Log in to comment or vote.